Product
Migalastat HCl
Aliases
AT1001, migalastat, migalastat HCl 150 mg
2 clinical trials
1 indication
Indication
Fabry DiseaseClinical trial
An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Subjects With Fabry Disease and Amenable GLA Variants and Severe Renal Impairment or End-Stage Renal Disease Treated With HemodialysisStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Long-term, Open-label Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Migalastat in Subjects > 12 Years of Age With Fabry Disease and Amenable GLA VariantsStatus: Active (not recruiting), Estimated PCD: 2025-12-01